Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 425.00
+1.00 (0.24%)
Feb 12, 2026, 4:59 PM GMT
Tristel Market Cap
Tristel has a market cap or net worth of 203.67 million as of February 12, 2026. Its market cap has increased by 15.42% in one year.
Market Cap
203.67M
Enterprise Value
196.70M
Revenue
46.46M
Ranking
n/a
PE Ratio
30.73
Stock Price
425.00
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 203.67M, an increase of 2,848.70%. That is a compound annual growth rate of 17.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 203.19M | 1.89% |
| Dec 31, 2025 | 199.42M | -1.61% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| PureTech Health | 311.77M |
| NIOX Group | 272.49M |
| Avacta Group | 260.26M |
| Integrated Diagnostics Holdings | 259.90M |